The renin-angiotensin system (RAS) is involved in the cardiac and vascular remodeling associated with cardiovascular diseases. Angiotensin (Ang) II/AT 1 axis is known to promote cardiac hypertrophy and collagen deposition. In contrast, Ang-(1-7)/Mas axis opposes Ang II effects in the heart producing anti-trophic and anti-fibrotic effects. Exercise training is known to induce cardiac remodeling with physiological hypertrophy without fibrosis. We hypothesize that cardiac remodeling induced by chronic exercise depends on the action of Ang-(1-7)/Mas axis. Thus, we evaluated the effect of exercise training on collagen deposition and RAS components in the heart of FVB/N mice lacking Mas receptor (Mas-KO). Male wild-type and Mas-KO mice were subjected to a moderate-intense swimming exercise training for 6 weeks. The left ventricle (LV) of the animals was sectioned and submitted to qRT-PCR and histological analysis. Circulating and tissue angiotensin peptides were measured by RIA. Sedentary Mas-KO presented a higher circulating Ang II/Ang-(1-7) ratio and an increased ACE2 expression in the LV. Physical training induced in Mas-KO and WT a similar cardiac hypertrophy accompanied by a pronounced increase in collagen I and III mRNA expression. Trained Mas-KO and trained WT presented increased Ang-(1-7) in the blood. However, only in trained-WT there was an increase in Ang-(1-7) in the LV. In summary, we showed that deletion of Mas in FVB/N mice produced an unbalance in RAS equilibrium increasing Ang II/AT 1 arm and inducing deleterious cardiac effects as deposition of extracellular matrix proteins. These data indicate that Ang-(1-7)/Mas axis is an important counter-regulatory mechanism in physical training mediate cardiac adaptations.
Introduction
Cardiac hypertrophy is characterized by myocardic tissue growth as a consequence of an increase in cardiomyocyte protein synthesis and extracellular matrix deposition [2, 12] . Cardiac remodeling follows several diseases including arterial hypertension and valve stenosis (pathological hypertrophy) or as the result of chronic exercise or pregnancy (physiological hypertrophy) [12] . Pathological cardiac hypertrophy is characterized by a thickening of the heart muscle which results in a decrease in the size of the heart chambers, including the left and right ventricles leading to diastolic dysfunction and later to systolic dysfunction [2, 12] .
It is well established that the renin-angiotensin system (RAS) plays an important role in the progression of cardiac remodeling. The decrease in the overactivity of the angiotensin converting enzyme (ACE)/angiotensin (Ang) II/Ang II type 1 receptor (AT 1 ) classical arm of RAS provides protection from pathological cardiac hypertrophy and subsequent heart failure [12, 38] . Ang II, through its interactions with the AT 1 receptor, has been demonstrated to increase fibroblast gene expression (including collagen), fibroblast density and proliferation, and myocyte hypertrophy, all of them are hallmarks of myocardial fibrosis and remodeling [12, 14] . On the other hand, ACE2 has been shown to have a high affinity to hydrolyse Ang II [16] , the pressor, hypertrophic/profibrotic hormone of the RAS, leading to the formation of Ang-(1-7), which presents vasodilator, anti-trophic and antifibrotic effects [6, 9, 13, 23, 25] . Thus, a balance between the activities of these two arms of the RAS is important to keep cardiovascular homeostasis. Open access under the Elsevier OA license.
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Table 1
Body weight (BW), left ventricle weight and the ratio left ventricle weight/body weight in WT and Mas KO mice sedentary and submitted to exercise training (trained).
Groups (n)
Initial It has been well documented in the heart that Ang-(1-7) presents several actions that oppose those of Ang II [36, [38] [39] [40] . Most of the Ang-(1-7) actions are mediated by the Mas receptor [41] , which is present in the heart and have an important role improving heart function in isolated-heart reperfusion technique [19, 37, 39] . It was demonstrated that expression of an Ang-(1-7)-producing fusion protein produces cardioprotective effects in rats [39] and that chronic Mas-deficiency leads to impaired calcium handling in cardiomyocytes revealing a key role for the Ang-(1-7)/Mas axis as a modulator of cardiomyocyte function [13, 23] . Recently, Ferreira et al. [19] and Marques et al. [30] showed that increased Ang-(1-7) in the heart attenuates isoproterenol-induced cardiac fibrosis in transgenic rats [19] and that an oral formulation of Ang-(1-7) produces cardioprotective effects in rats with coronary occlusion [30] . In addition, chronic infusion of Ang-(1-7) also prevents the cardiac fibrosis produced in the DOCA-salt rat model [24, 25] . More recently we have shown that lifetime overproduction of Ang-(1-7) attenuates DOCA-salt hypertension-induced cardiac dysfunction and remodeling [36] . Collectively, these findings led us to the hypothesis that the Ang-(1-7)/Mas axis could have a role in the physiological cardiac remodeling induced by chronic exercise, thus the aim of the present study was to compare the alterations in components of the RAS and extracellular matrix in the heart of FVB/N mice lacking Mas receptor (Mas-KO) submitted to aerobic swimming training.
Materials and methods

Animals
Twelve-weeks-old male FVB/N wild-type and FVB/N Mas-KO mice were used. Mice were maintained at the Transgenic Animal Facilities of the Laboratory of Hypertension/INCT (Federal University of Minas Gerais, Belo Horizonte, Brazil) and were treated according to the international guidelines for animal care. The experimental protocol was approved by the Ethics Committee in animal experimentation of the Federal University of Minas Gerais (protocol no. 009/08). Animals were divided into 4 groups: Mas-KO sedentary, Mas-KO trained, WT sedentary, and WT trained, and maintained under controlled light and temperature conditions and had free access to water and standard diet.
Physical training
We define the intensity of 80% of maximum capacity for being considered a moderate-intensity close to anaerobic threshold. Although we have not determined anaerobic threshold it has been already demonstrated that it usually occurs between 50% and 80% of maximum capacity [31, 45] . Furthermore, several studies have suggested intensities near to the anaerobic threshold in animals with heart failure [27] and humans [5] to promote cardiovascular capacity improvement.
Mas-KO and WT FVBN mice were subjected to a swimming exercise training with a workload attached to their tail corresponding to 80% of the maximum load (ML) adjusted for each animal, according to Evangelista et al. [17] . Initially the animals were submitted to a 7 days of adaptation period which consisted of swimming exercise sessions with a workload of 2% of body weight attached to the tail with subsequent duration of 20, 40 and 60 min in days 1-3, respectively. On the 4th day, they were submitted to the maximum workload test. Days 5-7 animals swam with 80% ML for 20, 40 and 60 min, respectively. This load was then kept for the first two weeks of training. Mice swam for 6 weeks, 5 days per week, once a day for 1 h, in water tanks with the water kept at 30 • C with a thermostat to avoid thermal stress. The swimming training was conducted between 9 and 11 am. The maximum workload test was repeated at the 1st day of the third and fifth week of training in order to adjust the workload to 80% ML throughout the training period. Constant monitoring was given to ensure the safety of the mice [17] . Sedentary mice were placed in water tanks for 5 min daily to mimic the water stress.
Tissue and blood collection
Twenty four hours after the last session of swimming exercise mice were killed by decapitation and the trunk blood was rapidly collected into chilled polypropylene tubes containing guanidine thiocyanate and centrifuged, as described previously [42] . Simultaneously, the heart was excised and dissected onto ice. Left ventricle (LV) was weighted and divided in three transversal portions: base, median and apex. Base and apex were snapped frozen and the median segment of LV was processed for histology. Total blood and LV segments were kept in −80 • C until assayed.
Reverse transcription and real-time PCR
Total RNA from the apex segment of the LV was prepared using TRIzol reagent (Invitrogen, San Diego, CA), treated with DNAse, and reverse transcribed with MML-V (Moloney murine leukemia virus) (Invitrogen) [43] . The endogenous HPRT -hypoxanthine guanine phosphoribosyltransferase (internal control), collagen I, collagen III, fibronectin, angiotensin converting enzyme (ACE), ACE 2 and AT1 receptor cDNA were amplified using specific primers (Table 1) and SYBR green reagent (Applied Biosystems) in an ABI Prism 7000 platform (Applied Biosystems). The relative comparative CT method of Livak and Schmittgen was applied to compare gene expression levels between groups, using the equation 2 − CT [29] .
Histological analysis
Median LV segment was fixed in Bouin solution (4% at 4 • C) for 24 h, washed with water and maintained in 70% ethanol overnight. Subsequently, tissue was embedded in paraffin, sectioned (5 m) and stained with hematoxylin and eosin. Images from 3 slides of each animal were captured and cardiac fibers from at least 150 cells of each group were measured using LC Evolution/Olympus Bx50 using a 40× objective. Cardiomyocytes were analyzed only from longitudinal fibers with well defined central nucleus. 
Ang-(1-7) and Ang II measurements
The segment from the base of the LV was homogenized in 4 mol/L of guanidine thiocyanate/1% trifluoroacetic acid (vol/vol; 5 ml for each tissue) in water and then processed as described previously [8, 36] . Blood and LV peptides were extracted onto bondelut phenylsilane cartridges (Varian) and Ang-(1-7) and Ang II immunoreactivity (ir) was measured by radioimmunoassay, as described previously by Botelho et al. [7] .
Statistical analysis
Data are expressed as mean ± SE. Comparisons between two observations in the same animal or two groups were performed by Student t-test paired or not paired, respectively. Differences among more than 2 groups were assessed by two-way ANOVA followed by the Bonferroni test. The statistical analysis was performed with GraphPad Prism software (version 4.0), and the level of significance was set at p < 0.05.
Results
Comparison between sedentary Mas-KO and WT mice
As observed in Table 1 , sedentary WT mice gained weight during the 6 weeks period (36.0 ± 0.8 g) in comparison to their initial weight (30.0 ± 0.6 g), while sedentary Mas-KO mice did not significantly alter body weight (Table 1 ). In the sedentary group, Ang II levels in the blood of Mas-KO (141 ± 38 pg/ml; Fig. 1) were not significantly different from WT (105 ± 8 pg/ml; Fig. 1 ). However, Ang-(1-7) was significantly lower in Mas-KO (41 ± 6 pg/ml) as compared to WT (137 ± 9 pg/ml; Fig. 1 ). The ratio of circulating Ang II/Ang-(1-7) in the blood of Mas-KO mice was 3.5 while in WT it was 0.7, which pointed out for a strong unbalance in circulating RAS with a predominance of Ang II in Mas-KO. No differences were observed in the concentrations of angiotensin peptides in the LV [Ang II: 6 ± 2 pg/mg vs 5 ± 1 pg/mg in WT; Ang-(1-7): 33 ± 6 pg/mg vs 34 ± 4 pg/mg in WT; Fig. 1] .
Analysis of mRNA expression in the LV showed a higher expression of ACE2 in Mas-KO mice (3.98 ± 0.68 AU vs 1.0 ± 0.16 AU in WT; Fig. 2 ), accompanied by no difference in the expression of ACE or AT 1 receptor in comparison to WT (Fig. 2) . In addition, while collagen I and fibronectin mRNA expression were not different, collagen III expression was significantly lower in Mas-KO (0.37 ± 0.02 AU vs 1.0 ± 0.1 AU in WT; Fig. 3 ). No differences were observed in body weight, cardiomyocyte diameter and LV weight in Mas-KO in comparison to WT sedentary animals ( Table 1) .
Effect of swimming training on blood and LV angiotensin components in Mas-KO mice
Six weeks of physical training did not change the body weight of Mas KO or WT mice compared with pre-exercise values (Table 1) . Physical training induced similar increase (∼10%) in cardiomyocyte diameter in Mas-KO (11 ± 0.2 m vs 10 ± 0.2 m in sedentary Mas-KO; Fig. 4 ) and in WT (10 ± 0.2 m vs 9 ± 0.2 in sedentary WT; Fig. 4 ). The change in cardiomyocyte diameter was accompanied by an increase in mRNA expression of collagen I, collagen III and fibronectin in Mas-KO mice. In WT mice there was a tendency to increase collagen I, however only fibronectin expression was significantly augmented (two way ANOVA; Fig. 3 ).
Physical training induced significant increase in Ang-(1-7) in the blood of Mas-KO (491 ± 53 pg/ml vs 41 ± 6 pg/ml in sedentary Mas-KO; Fig. 1 ) and in WT mice (244 ± 33 pg/ml vs 137 ± 9 pg/ml in sedentary WT; Fig. 1 ). As seen in Fig. 1 , this increase was higher in trained Mas-KO (491 ± 53 pg/ml) in comparison to trained WT (244 ± 33 pg/ml). Interestingly, there was an increase in Ang-(1-7) levels (∼2 fold) in the LV only in trained WT (80 ± 16 pg/ml vs 34 ± 4 pg/ml in sedentary WT). In contrast, trained Mas-KO presented an increase in Ang II levels in the blood (331 ± 73 pg/ml vs 141 ± 38 pg/ml in sedentary Mas-KO; Fig. 1 ) and in the LV (62 ± 10 pg/mg protein vs 4.2 ± 0.61 pg/mg protein in sedentary Mas-KO; Fig. 1 ). No changes in Ang II levels were observed in trained expression (3 ± 0.8 AU vs 1 ± 0.4 AU in control WT; Fig. 2 ) and a 70% decrease in ACE2 expression (Fig. 2) . No significant alteration was induced by exercise in the expression of ACE, ACE2 or AT 1 in Mas-KO mice (Fig. 2) . Thus, comparing the ratio ACE/ACE2 in WT mice, we observed that exercise training in WT mice induced a great reduction in ACE/ACE2 balance (0.001 vs 1.0 compared to sedentary WT mice). However, in trained Mas-KO exercise there was an increase in ACE/ACE2 ratio (0.10 vs 0.03 in sedentary Mas-KO mice). These changes will favor Ang-(1-7) accumulation in WT, but not in Mas-KO mice, in which the accumulation of Ang II is being favored.
Discussion
The main result of the present study was the observation that 6 weeks of swimming training in FVB/N mice lacking Mas induced cardiac hypertrophy which was associated to an increase in collagen I and III mRNA expression. The increase in collagen may be related to an inversion of the balance between Ang II and Ang-(1-7) actions in the heart of Mas-KO, favoring a stronger and unopposed influence of Ang II. Further, our data showed that the lack of Mas receptor produces a reduction in circulating levels of Ang-(1-7) resulting in an systemic unbalance of Ang II/Ang-(1-7) relationship.
The role of the RAS on the development of cardiovascular system hypertrophy has been well studied. It is well documented that Ang II acting through AT 1 receptor produces a hypertrophic and profibrotic effect in heart [12, 14] . Different studies have shown that ACE2 and Ang-(1-7) exert an important role on cardiovascular homoeostasis producing vasodilatation in different territories and cardiac/vascular antifibrotic and antitrophic effects [6, 9, 36] that oppose those of Ang II actions. In addition, Ang-(1-7) inhibits cardiac myocytes growth through activation of the Mas receptor [13] preventing pathological remodeling through NO/cGMP dependent pathway [13, 23] . The present findings reinforce the importance of Ang-(1-7)/Mas axis in cardiovascular hypertrophy by showing that Mas deletion induces deleterious effects in the heart of trained mice. Mas-KO trained animals presented an increased expression of matrix proteins probably due to the lack of Mas-mediated actions of Ang-(1-7), associated to an increase in Ang II and AT 1 levels in the heart. Previous studies using echocardiography have shown that Mas deficient mice present an impaired heart function with lower systolic tension and lower heart rate accompanied by a significantly decreased fractional shortening and posterior wall thickness in systole, and a higher left ventricle end-systolic and end-diastolic dimensions, indicating a markedly lower global ventricular function [37] . An impaired cardiac function during ischemia/reperfusion was also shown in Mas-KO mice [9] . These data indicate that Ang-(1-7)/Mas is importantly related to a normal cardiac function [39, 40] . These data indicate that Ang-(1-7)/Mas is importantly related to a normal cardiac function. Although cardiac dynamics data are not provided, our results advances this hypothesis by showing that exercise in Mas-KO mice induces pre-fibrotic effects probably due to an exaggerated and unopposed effect of Ang II. In addition, these data suggest that exercise may not improve cardiac function in Mas-KO mice. Future studies should address the impact of these changes in the cardiac dynamics of animals submitted to physical exercise.
Swimming training induced similar hypertrophy in Mas-KO and WT mice, since cardiomyocytes diameter and relative LV weight were increased approximately by the same proportion (10%) in both groups. In a previous study, we showed that Mas deficient C57/BL6 mice presented altered extracellular matrix components with an increase in collagen and fibronectin expression in LV, suggesting an antifibrotic action of Ang-(1-7)/Mas axis [37] . Our present data advanced these observations by showing that Mas-KO mice submitted to moderate-intense physical training presented an increased expression of collagen I and collagen III compared to trained WT or sedentary Mas-KO mice. These data suggest that Ang-(1-7) through Mas may exert a compensatory mechanism counteracting an increase in extracellular matrix after chronic exercise.
One can argue that the LV hypertrophy would be higher in Mas-KO mice submitted to exercise than in the controls. Nevertheless, we have shown that Mas-KO mice have an increased collagen deposition after physical exercise, which is probably independent of the hypertrophy. Other studies have shown that cardiac hypertrophy and fibrosis may not be linked phenomena and the signaling pathways leading to the hypertrophic and profibrotic response of the heart to similar stimulus are distinct [10, 11, 35] . In the present study, although the hypertrophy to exercise was similar in WT and Mas-KO, our data show that an increase in Ang II, without Ang-(1-7) action, may lead to pre-fibrotic lesions in the heart of mice submitted to exercise. Exercise cardiac hypertrophy is considered to be an adaptive beneficial physiological phenomenon triggered by the cardiac metabolic demand and hemodynamic changes that occurs during repeated exercise bout [18, 21, [46] [47] [48] . Further, these stimuli may not be directly affected by RAS unbalance, at least in mice and in the protocol and time point of our study. Even in pathological hypertrophy induced, for instance, by hypertension dissociation between hypertrophy and pre-fibrotic lesions in the heart are observed. Previous studies in the DOCA-salt hypertensive model have shown that chronic Ang-(1-7) treatment prevented cardiac fibrosis but not hypertrophy, and the Ang-(1-7) infusion had no effect on the DOCA-salt hypertension or blood pressure responses to intravenous Ang II [24, 25] . Recently, we have shown [36] that transgenic rats with systemic overexpression of Ang-(1-7) presented attenuated hypertension and cardiac hypertrophy and fibrosis when subjected to DOCA-salt hypertension model. Further, in this study these effects were accompanied by a remarkable (∼4 times) increase in Ang-(1-7) in the left ventricle. Thus, we believe that the different results on cardiac hypertrophy vs fibrosis vs high blood pressure among these studies may be related to levels of Ang-(1-7) that can be achieved locally in the heart, i.e., a direct cardiac protective action of Ang-(1-7) in the heart (supported by studies in vivo, as cited above, and in cultured fibroblasts and myocytes), completely independent from the arterial pressure regulatory functions of Ang- (1-7) .
The extracellular matrix deposition is regulated by Ang II in different pathologies as demonstrated in several studies [12, 14, 49] . Ang II controls collagen and fibronectin synthesis in cardiac dysfunction [44] and Ang-(1-7)/Mas axis can reduce the hypertrophic and profibrotic effects induced by Ang II [38, 40, 49] . In addition, several studies showed that chronic treatment with AT 1 antagonists or ACE inhibitors can reverse or attenuate fibrosis in the heart [28, 44] . Different models of exercise training and/or Ang II receptor blockade post myocardial infarction show reduction in matrix metalloproteinase 1 expression and mitigates the expressions of ACE and AT 1 in rats [44] . These effects can be partially attributed to an increase in Ang-(1-7) levels that is induced by AT 1 blockade or ACE inhibition, since chronic administration of these drugs increase Ang-(1-7) production [33] . Our data reinforce the hypothesis that Ang-(1-7)/Mas axis produces antifibrotic effects in the heart and, further, suggest that the absence of Ang-(1-7)/Mas action can lead to collagen deposition after physical training.
In the present study we observed that in sedentary animals, circulating Ang-(1-7) was decreased in Mas-KO compared to WT, resulting in a much higher Ang II/Ang-(1-7) ratio. Interestingly, in both trained WT and Mas-KO mice an important increase in circulating Ang-(1-7) was observed. The increase in Ang-(1-7) post-training may be related to cardioprotection induced by exercise through vasodilatation increase, autonomic function improvement and nitric oxide release. However, the LV level of Ang-(1-7) was increased only in trained WT mice. This result is in keeping with the study of Filho et al. [20] that showed that spontaneously hypertensive rats subjected to physical training presented selective increase in Ang-(1-7) level and Mas receptor expression in the heart, suggesting that the beneficial effect induced by swimming training in hypertensive rats might include an augmentation of Ang-(1-7)/Mas axis activation in the heart. Further, our data suggest that the lack of Mas may impair the increase in Ang-(1-7) levels in the heart pointing to a specific tissue control effect of Mas receptor in the heart [20] . One possibility, which was previously shown for Ang II [32, 34] , is that the increase in Ang-(1-7) levels in the LV could be due to an uptake of the peptide from the circulation, and Mas receptor deficiency impair, at least in part, the cardiac accumulation of Ang-(1-7). The increased levels of Ang-(1-7) in the circulation and the decreased levels in the heart in Mas-KO mice are in keeping with this hypothesis. Further, our present data suggest that this putative mechanism may depend on an interaction of Ang-(1-7) with its receptor Mas.
Another possibility is that Ang-(1-7) acting though Mas would alter the expression of the main RAS enzymes, ACE and ACE2, favoring the degradation of Ang II and the buildup of Ang-(1-7). In fact, while trained WT rats presented a decrease in ACE and ACE2 expression, no alteration was observed in trained Mas-KO mice. In line with this observation, ACE2 expression in sedentary Mas-KO was increased in the heart. Studies have shown that Ang II can reduce ACE2 expression in cardiomyocytes in culture and Ang-(1-7) has no direct effect [26] . In astrocytes, Ang-(1-7) had no direct effect but attenuated the Ang II inhibitory effect on ACE2 expression [22] .
The cardiac effects observed in Mas-KO mice cannot be attributable only to the lack of Ang-(1-7) action, since circulating and cardiac Ang II were augmented in Mas-KO, but not in trained WT mice, which certainly contributed to worsen the equilibrium of the RAS peptides balance in the heart. In Mas-KO mice there was smaller decrease in ACE accompanied by no change in ACE2 expression, which resulted in an increased ratio ACE/ACE2. This effect is in keeping with the increased levels of Ang II in the hearts of Mas-KO mice. Interestingly, based on the studies of Ishiyama et al. [26] we could expect that cardiac ACE2 would decrease in Mas-KO mice due to the increase in Ang II in the LV. Future studies will be necessary to further clarify the effect of Ang II and Ang-(1-7) on the RAS enzyme, ACE and ACE2, in the mouse heart.
In trained WT mice we observed a decrease in LV ACE (∼90%) and ACE2 (∼70%) expression resulting in a high decrease in the ratio ACE/ACE2 which will favor Ang-(1-7) building up in the heart. It is well known the ACE breaks down Ang-(1-7) producing an inactive peptide, Ang-(1-5) [1] . Thus, the relative higher decrease in ACE in comparison to ACE2 will decrease the degradation of Ang-(1-7). We have previously observed that in DOCA salt-induced hypertension in transgenic rats, that presents an overexpression of Ang-(1-7) in the circulation, there was an increase in Ang-(1-7) in the heart that was accompanied by a decrease in ACE and ACE2 mRNA expression [36] . Taken together, these data support our hypothesis of a modulatory role for Ang-(1-7) in the expression of ACE and ACE2 in the heart. Interestingly, the expression of AT 1 mRNA was higher in trained WT mice, which may reflect an upregulation of the receptor in response to the large relative reduction of Ang II [3, 4] . In addition, it is known that AT 1 participates in the cardiac hypertrophic mechanisms independent of alterations in heart Ang II levels [15, 50] . Another possible mechanism can involve direct activation of AT 1 by cardiomyocyte stretch as demonstrated in previous studies [49] .
Conclusion
In summary, the results obtained in the present study show that genetic deletion of Mas in FVB/N mice produced an unbalance in RAS equilibrium increasing Ang II/AT 1 arm activation in the heart. An important finding of the present study was to show that moderate-intense swimming training in Mas-KO mice induced cardiac hypertrophy accompanied by a pronounced increase in collagen I and III mRNA expression. Unlike trained WT mice, where there was a marked increase in Ang-(1-7) levels in the LV, trained Mas-KO presented a pronounced increased in Ang II. Thus, the cardiac pro-fibrotic effect observed in Mas-KO after training maybe related to a stronger and unopposed influence of Ang II. These data show that Ang-(1-7) acting through Mas receptor produces an important counter-regulatory role in physical training mediate cardiac adaptations. These data indicate that pharmacological strategies that lead to an increase in Ang-(1-7) or another Mas receptor agonist in the heart may be an additional important mechanism to oppose Ang II induced collagen deposition in patients with cardiovascular disease.
